TIAA CREF Investment Management’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

TIAA CREF Investment Management’s Portfolio PRNB Stock Details PRNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$359K	Buy	+10,554	New	+$336K	﹤0.01%	2721

Other funds holding PRNB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TIAA CREF Investment Management's PRNB Position: Q1 2019 in Review

TIAA CREF Investment Management opened a new position in Principia Biopharma Inc. Common Stock (PRNB) in Q1 2019: 10,554 shares worth $359K. The stake represents ﹤0.01% of the portfolio and ranks #2721 among its holdings.

62 funds tracked by Wall St. Rank hold PRNB as of Q1 2019.

TIAA CREF Investment Management held 10,554 shares of Principia Biopharma Inc. Common Stock worth $359K as of Q1 2019.
Principia Biopharma Inc. Common Stock was a new TIAA CREF Investment Management position in Q1 2019.
Principia Biopharma Inc. Common Stock made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2721 holding.
62 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.